366 related articles for article (PubMed ID: 32411144)
1. MR1-Restricted T Cells Are Unprecedented Cancer Fighters.
Vacchini A; Chancellor A; Spagnuolo J; Mori L; De Libero G
Front Immunol; 2020; 11():751. PubMed ID: 32411144
[TBL] [Abstract][Full Text] [Related]
2. Antigen Recognition by MR1-Reactive T Cells; MAIT Cells, Metabolites, and Remaining Mysteries.
Corbett AJ; Awad W; Wang H; Chen Z
Front Immunol; 2020; 11():1961. PubMed ID: 32973800
[TBL] [Abstract][Full Text] [Related]
3. T cell receptor diversity, specificity and promiscuity of functionally heterogeneous human MR1-restricted T cells.
Lepore M; Lewinsohn DA; Lewinsohn DM
Mol Immunol; 2021 Feb; 130():64-68. PubMed ID: 33360378
[TBL] [Abstract][Full Text] [Related]
4. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.
Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O
Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347
[TBL] [Abstract][Full Text] [Related]
5. Functionally diverse human T cells recognize non-microbial antigens presented by MR1.
Lepore M; Kalinichenko A; Calogero S; Kumar P; Paleja B; Schmaler M; Narang V; Zolezzi F; Poidinger M; Mori L; De Libero G
Elife; 2017 May; 6():. PubMed ID: 28518056
[TBL] [Abstract][Full Text] [Related]
6. The burgeoning role of MR1-restricted T-cells in infection, cancer and autoimmune disease.
Crowther MD; Sewell AK
Curr Opin Immunol; 2021 Apr; 69():10-17. PubMed ID: 33434741
[TBL] [Abstract][Full Text] [Related]
7. MAIT Cells Promote Tumor Initiation, Growth, and Metastases via Tumor MR1.
Yan J; Allen S; McDonald E; Das I; Mak JYW; Liu L; Fairlie DP; Meehan BS; Chen Z; Corbett AJ; Varelias A; Smyth MJ; Teng MWL
Cancer Discov; 2020 Jan; 10(1):124-141. PubMed ID: 31826876
[TBL] [Abstract][Full Text] [Related]
8. MR1, an immunological periscope of cellular metabolism.
Chancellor A; Vacchini A; De Libero G
Int Immunol; 2022 Feb; 34(3):141-147. PubMed ID: 34718585
[TBL] [Abstract][Full Text] [Related]
9. Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells.
Jin H; Ladd NA; Peev AM; Swarbrick GM; Cansler M; Null M; Boughter CT; McMurtrey C; Nilsen A; Dobos KM; Hildebrand WH; Lewinsohn DA; Adams EJ; Lewinsohn DM; Harriff MJ
Sci Rep; 2022 Dec; 12(1):22539. PubMed ID: 36581641
[TBL] [Abstract][Full Text] [Related]
10. MAIT cells and MR1-antigen recognition.
Keller AN; Corbett AJ; Wubben JM; McCluskey J; Rossjohn J
Curr Opin Immunol; 2017 Jun; 46():66-74. PubMed ID: 28494326
[TBL] [Abstract][Full Text] [Related]
11. MR1-restricted T cells: the new dawn of cancer immunotherapy.
Wang Z; Wang M; Chen J; Zhang L; Zhang L; Yu L
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185693
[TBL] [Abstract][Full Text] [Related]
12. MR1 antigen presentation to MAIT cells and other MR1-restricted T cells.
McWilliam HEG; Villadangos JA
Nat Rev Immunol; 2024 Mar; 24(3):178-192. PubMed ID: 37773272
[TBL] [Abstract][Full Text] [Related]
13. Postnatal Expansion, Maturation, and Functionality of MR1T Cells in Humans.
Swarbrick GM; Gela A; Cansler ME; Null MD; Duncan RB; Nemes E; Shey M; Nsereko M; Mayanja-Kizza H; Kiguli S; Koh J; Hanekom WA; Hatherill M; Lancioni C; Lewinsohn DM; Scriba TJ; Lewinsohn DA
Front Immunol; 2020; 11():556695. PubMed ID: 33042140
[TBL] [Abstract][Full Text] [Related]
14. Mouse mucosal-associated invariant T cell receptor recognition of MR1 presenting the vitamin B metabolite, 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil.
Ciacchi L; Mak JYW; Le JP; Fairlie DP; McCluskey J; Corbett AJ; Rossjohn J; Awad W
J Biol Chem; 2024 May; 300(5):107229. PubMed ID: 38537698
[TBL] [Abstract][Full Text] [Related]
15. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?
Mondot S; Boudinot P; Lantz O
Immunogenetics; 2016 Aug; 68(8):537-48. PubMed ID: 27393664
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Human Mucosal-associated Invariant T (MAIT) Cells.
Souter MNT; Loh L; Li S; Meehan BS; Gherardin NA; Godfrey DI; Rossjohn J; Fairlie DP; Kedzierska K; Pellicci DG; Chen Z; Kjer-Nielsen L; Corbett AJ; McCluskey J; Eckle SBG
Curr Protoc Immunol; 2019 Dec; 127(1):e90. PubMed ID: 31763790
[TBL] [Abstract][Full Text] [Related]
17. Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens.
Meermeier EW; Laugel BF; Sewell AK; Corbett AJ; Rossjohn J; McCluskey J; Harriff MJ; Franks T; Gold MC; Lewinsohn DM
Nat Commun; 2016 Aug; 7():12506. PubMed ID: 27527800
[TBL] [Abstract][Full Text] [Related]
18. How MR1 Presents a Pathogen Metabolic Signature to Mucosal-Associated Invariant T (MAIT) Cells.
McWilliam HEG; Villadangos JA
Trends Immunol; 2017 Sep; 38(9):679-689. PubMed ID: 28688841
[TBL] [Abstract][Full Text] [Related]
19. Production of MR1 Tetramers Loaded with Microbial Ligands.
Ladd NA; Froyd CA; Adams EJ
Methods Mol Biol; 2020; 2098():191-207. PubMed ID: 31792824
[TBL] [Abstract][Full Text] [Related]
20. Role of CD1d- and MR1-Restricted T Cells in Asthma.
Iwamura C; Nakayama T
Front Immunol; 2018; 9():1942. PubMed ID: 30210497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
